Note: Ingredients listed on restricted chemical lists
EC/CAS
103-90-2
Name of the chemical
N-(4-hydroxyphenyl) acetamide
Concentration
N/A
EC/CAS
209-151-9
Name of the chemical
Aluminium, zinc, magnesium and calcium stearates
Concentration
N/A
EC/CAS
209-150-3
Name of the chemical
Aluminium, zinc, magnesium and calcium stearates
Concentration
N/A
General Information
Revision date
2020-10-05
Product name
EXCEDRIN PM HEADACHE CAPLETS (MFC51321)
Product Synonyms
MFC51321
1.2.1 Relevant identified uses
This safety data sheet is written to provide health, safety and environmental information for people
Emergency telephone
VERISK 3E GLOBAL INCIDENT RESPONSE
Icons in SDS
Company Information
company name
GlaxoSmithKline UK
e-mail address of the competent person responsible for the Safety Data Sheet
msds@gsk.com
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H302, H315, H319, H412
Hazard statements
Code
Statements
H302
Harmful if swallowed
Section 2
2.1 Classification of the substance or mixture
The mixture has been assessed and/or tested for its physical, health and environmental hazards and the following classification applies.
EU Classification
Regulation (EC) No 1272/2008 as amended
Health hazards
Acute toxicity, oral Category 4 H302 - Harmful if swallowed. Skin corrosion/irritation Category 2 H315 - Causes skin irritation. Serious eye damage/eye irritation Category 2 H319 - Causes serious eye irritation.
Environmental hazards
Hazardous to the aquatic environment, Category 3 H412 - Harmful to aquatic life with long-term aquatic hazard long lasting effects. Hazard summary Harmful if swallowed. Causes serious eye irritation. Causes skin irritation. Dangerous for the environment if discharged into watercourses. Occupational exposure to the substance or mixture may cause adverse health effects.
2.2 Label elements
Label according to Regulation (EC) No. 1272/2008 as amended
Contains
ASPIRIN, DIPHENHYDRAMINE CITRATE, MAGNESIUM STEARATE, MICROCRYSTALLINE CELLULOSE, PARACETAMOL
Signal word
Warning
Hazard statements
H302 Harmful if swallowed. H315 Causes skin irritation. H319 Causes serious eye irritation. H412 Harmful to aquatic life with long lasting effects.
Prevention
P264 Wash thoroughly after handling. P270 Do not eat, drink or smoke when using this product. P273 Avoid release to the environment. P280 Wear eye protection/face protection. P280 Wear protective gloves.
Response
P301 + P312 IF SWALLOWED: Call a POISON CENTRE/doctor/ if you feel unwell. P330 Rinse mouth. P302 + P352 IF ON SKIN: Wash with plenty of water/. P305 + P351 + P338 IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P321 Specific treatment (see on this label). P332 + P313 If skin irritation occurs: Get medical advice/attention. P337 + P313 If eye irritation persists: Get medical advice/attention. P362 + P364 Take off contaminated clothing and wash it before reuse.
Storage
Not available.
Disposal
P501 Dispose of contents/container in accordance with local/regional/national/international regulations.
Supplemental label elements
6.9 % of the mixture consists of component(s) of unknown acute oral toxicity. 99.2 % of the mixture consists of component(s) of unknown acute dermal toxicity. 63.7 % of the mixture consists of component(s) of unknown acute hazards to the aquatic environment. 34.4 % of the mixture consists of component(s) of unknown long-term hazards to the aquatic environment.
2.3 Other hazards
This mixture does not meet vPvB / PBT criteria of Regulation (EC) No 1907/2006, Annex XIII.
